Lena E Friberg Selected Research

Piperacillin

10/2022	Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.
3/2020	Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy.
1/2020	Erratum to: Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
1/2020	Population Pharmacokinetics of Piperacillin following Continuous Infusion in Critically Ill Patients and Impact of Renal Function on Target Attainment.
10/2019	Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
1/2019	Piperacillin pharmacokinetics and target attainment in children with cancer and fever: Can we optimize our dosing strategy?
1/2018	Population Pharmacokinetics of Piperacillin in Sepsis Patients: Should Alternative Dosing Strategies Be Considered?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lena E Friberg Research Topics

Disease

29	Neoplasms (Cancer) 10/2022 - 11/2004
28	Infections 10/2022 - 03/2009
11	Neutropenia 01/2020 - 07/2007
9	Breast Neoplasms (Breast Cancer) 10/2021 - 05/2005
7	Critical Illness (Critically Ill) 03/2020 - 08/2012
5	Body Weight (Weight, Body) 01/2020 - 01/2017
3	Pneumonia (Pneumonitis) 10/2022 - 01/2017
3	Febrile Neutropenia 10/2022 - 04/2012
3	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2004
3	Fever (Fevers) 10/2022 - 04/2012
3	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2016
3	Bacterial Infections (Bacterial Infection) 09/2020 - 10/2019
3	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 01/2006
2	Ventilator-Associated Pneumonia 06/2022 - 01/2018
2	Urinary Tract Infections (Urinary Tract Infection) 11/2021 - 01/2017
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 02/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020 - 10/2012
2	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2012
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2013 - 05/2009
2	Poisoning 12/2007 - 08/2005
1	Soft Tissue Infections 07/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Merkel Cell Carcinoma 01/2022
1	Pyelonephritis 11/2021
1	Alopecia (Baldness) 08/2021
1	Acute Kidney Injury (Acute Renal Failure) 03/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Persistent Infection 01/2020
1	Fatigue 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hand-Foot Syndrome 01/2020
1	Gram-Negative Bacterial Infections 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Endotoxemia 01/2019
1	Multiple Sclerosis 01/2019
1	Renal Insufficiency (Renal Failure) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Healthcare-Associated Pneumonia 01/2018

Drug/Important Bio-Agent (IBA)

23	Pharmaceutical PreparationsIBA 10/2022 - 01/2010
11	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2018
10	Carbapenems (Carbapenem Antibiotics)IBA 10/2022 - 04/2016
10	Colistin (Coly-Mycin)FDA Link 06/2022 - 08/2012
7	Piperacillin FDA LinkGeneric 10/2022 - 01/2018
7	Docetaxel (Taxotere)FDA Link 10/2021 - 04/2012
7	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 02/2011
6	Meropenem (Merrem)FDA LinkGeneric 12/2020 - 04/2016
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	LactamsIBA 10/2022 - 10/2019
4	methanesulfonic acid (methanesulfonate)IBA 06/2022 - 08/2012
3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 10/2022 - 01/2019
3	apramycinIBA 10/2022 - 09/2021
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2016
3	Ado-Trastuzumab EmtansineIBA 04/2018 - 10/2012
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2010 - 11/2004
2	Gentamicins (Gentamicin)FDA LinkGeneric 11/2021 - 01/2012
2	atezolizumabIBA 01/2020 - 01/2019
2	Sunitinib (Sutent)FDA Link 01/2020 - 01/2020
2	InterleukinsIBA 01/2019 - 01/2018
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2017 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 09/2014 - 10/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 05/2009
1	Panitumumab (Vectibix)FDA Link 10/2022
1	Circulating Tumor DNAIBA 10/2022
1	Floxacillin (Flucloxacillin)IBA 07/2022
1	Penicillins (Penicillin)FDA Link 07/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	avelumabIBA 01/2022
1	astegolimabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	AminesIBA 11/2021
1	Amikacin (A.M.K)FDA LinkGeneric 11/2021
1	AminoglycosidesIBA 11/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Polymyxins (Polymyxin)IBA 09/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 06/2020
1	Minocycline (Cyclops)FDA LinkGeneric 06/2020
1	Axitinib (AG 013736)IBA 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	Tazobactam FDA LinkGeneric 10/2019
1	Cladribine FDA LinkGeneric 01/2019
1	B7-H1 AntigenIBA 01/2019
1	TabletsIBA 01/2019
1	Escherichia coli endotoxinIBA 01/2019
1	Lapatinib (GW572016)FDA Link 04/2018
1	Capecitabine (Xeloda)FDA Link 04/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	carbapenemaseIBA 01/2018
1	AlginatesIBA 01/2017

Therapy/Procedure

12	Therapeutics 10/2022 - 04/2016
10	Drug Therapy (Chemotherapy) 08/2021 - 03/2009
3	Continuous Renal Replacement Therapy 03/2020 - 01/2013
1	Radiotherapy 01/2021
1	Extracorporeal Membrane Oxygenation 01/2018
1	Adjuvant Chemotherapy 01/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2016